Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Profit Margin (Quarterly): -0.31% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -0.31% |
March 31, 2024 | 14.53% |
December 31, 2023 | 11.27% |
September 30, 2023 | -44.18% |
June 30, 2023 | -17.09% |
March 31, 2023 | 15.14% |
December 31, 2022 | 5.09% |
September 30, 2022 | 4.84% |
June 30, 2022 | -2.32% |
March 31, 2022 | 22.48% |
December 31, 2021 | 10.44% |
September 30, 2021 | 0.87% |
June 30, 2021 | -21.51% |
March 31, 2021 | 16.95% |
December 31, 2020 | 3.08% |
September 30, 2020 | -32.26% |
June 30, 2020 | -94.97% |
March 31, 2020 | 11.59% |
December 31, 2019 | 13.15% |
September 30, 2019 | 10.54% |
June 30, 2019 | 3.77% |
March 31, 2019 | 10.13% |
December 31, 2018 | -37.89% |
September 30, 2018 | 31.00% |
June 30, 2018 | 8.37% |
Date | Value |
---|---|
March 31, 2018 | 21.38% |
December 31, 2017 | 1.72% |
September 30, 2017 | 48.36% |
June 30, 2017 | 14.05% |
March 31, 2017 | 21.52% |
December 31, 2016 | 5.13% |
September 30, 2016 | 14.37% |
June 30, 2016 | 11.66% |
March 31, 2016 | 12.75% |
December 31, 2015 | 5.43% |
September 30, 2015 | 9.08% |
June 30, 2015 | 9.70% |
March 31, 2015 | 11.23% |
December 31, 2014 | 2.08% |
September 30, 2014 | 8.29% |
June 30, 2014 | 9.32% |
March 31, 2014 | 13.48% |
December 31, 2013 | 4.60% |
September 30, 2013 | 7.60% |
June 30, 2013 | 8.12% |
March 31, 2013 | 11.30% |
December 31, 2012 | 3.71% |
September 30, 2012 | 5.34% |
June 30, 2012 | 4.73% |
March 31, 2012 | 10.34% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-94.97%
Minimum
Jun 2020
22.48%
Maximum
Mar 2022
-4.38%
Average
4.84%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
CureVac NV | -502.5% |
Affimed NV | -10.03K% |
InflaRx NV | -217.8K% |
BioNTech SE | 15.91% |
Immatics NV | -96.09% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -3.69% |
Return on Assets | -1.09% |
Return on Invested Capital | -2.97% |
Gross Profit Margin (Quarterly) | 55.19% |
Operating Margin (Quarterly) | 4.71% |
Return on Net Operating Assets | -1.30% |